Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cellebrite DI (CLBT) Revenue (2020 - 2025)

Historic Revenue for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to $126.0 million.

  • Cellebrite DI's Revenue rose 1794.06% to $126.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $455.9 million, marking a year-over-year increase of 1836.5%. This contributed to the annual value of $401.2 million for FY2024, which is 2340.53% up from last year.
  • As of Q3 2025, Cellebrite DI's Revenue stood at $126.0 million, which was up 1794.06% from $113.3 million recorded in Q2 2025.
  • In the past 5 years, Cellebrite DI's Revenue ranged from a high of $126.0 million in Q3 2025 and a low of $53.3 million during Q1 2021
  • In the last 5 years, Cellebrite DI's Revenue had a median value of $76.7 million in 2023 and averaged $83.7 million.
  • In the last 5 years, Cellebrite DI's Revenue surged by 575.48% in 2022 and then soared by 2694.14% in 2024.
  • Over the past 5 years, Cellebrite DI's Revenue (Quarter) stood at $67.9 million in 2021, then increased by 9.0% to $74.0 million in 2022, then increased by 25.66% to $93.0 million in 2023, then rose by 17.24% to $109.0 million in 2024, then increased by 15.57% to $126.0 million in 2025.
  • Its Revenue was $126.0 million in Q3 2025, compared to $113.3 million in Q2 2025 and $107.5 million in Q1 2025.